Cephalon consolidates oncology professional into Draftfcb

Share this article:

Cephalon has consolidated its oncology business into Interpublic Group's Draftfcb.

The franchise includes Trisenox, which was with WPP's Sudler & Hennessey, and Treanda, which was with Omnicom's LyonHeart.

It's a purely professional-facing assignment, as those brands are not currently advertised to consumers. Draftfcb, which previously handled advertising for the company's alertness drug Nuvigil, will take over the oncology business sometime this quarter, Cephalon said.

Share this article:
close

Next Article in News

Email Newsletters

More in News

Sanofi expands Gaucher disease portfolio

Sanofi expands Gaucher disease portfolio

The oral medication Cerdelga joins Cerezyme in its Fabry disease arsenal. Sanofi expects the drug will be priced "on par" with Cerezyme, which goes for around $300,000 a year in ...

Amicus seeks to upset Fabry market

Amicus seeks to upset Fabry market

Phase-III tests indicate patients may be able to switch from injectable enzyme-replacement therapies, like Fabrazyme, to the firm's oral drug.

Five things for pharma marketers to know: Wednesday, August 20

Five things for pharma marketers to know: Wednesday, ...

Novartis explores the virtual care space, a court has dismissed a lawsuit against IPAB, Doctors Without Borders calls the Ebola outbreak "a complete disaster" and Pfizer becomes the first pharma ...